Theravance Biopharma TBPH Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's deferred tax assets and other non-current assets?
- Theravance Biopharma (TBPH) reported deferred tax assets and other non-current assets of $25.3M in Q1 2026.
- How has Theravance Biopharma's deferred tax assets and other non-current assets changed year-over-year?
- Theravance Biopharma's deferred tax assets and other non-current assets increased by 83.0% year-over-year, from $13.82M to $25.3M.
- What is the long-term trend for Theravance Biopharma's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Theravance Biopharma's deferred tax assets and other non-current assets has grown at a 59.0% compound annual growth rate (CAGR), from $2.45M to $24.88M.